The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease
Objective: To evaluate the positions of the conus medullaris in patients with Parkinson's disease(PD). To know the prevalence of isolated lipoma of filum terminale(LFT) in…Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease
Objective: An unmet need exists to develop a methodology to diagnose Parkinson's disease (PD) in the premotor stage, so that patients can be enrolled in…Cognitive profile of Filipino patients with X-linked dystonia parkinsonism
Objective: This study aims to provide a quantitative and qualitative description of the neuropsychological profile of patients diagnosed with X-linked dystonia-parkinsonism (XDP) given in a…Single-subject FDG PET patterns and cognitive dysfunctions in Parkinson’s disease
Objective: To evaluate [18]FDG-PET single-subject perfusion patterns in Parkinson's disease (PD) patients and their relationship with cognitive dysfunction and progression during five years of follow-up.…Fall prediction in Parkinson’s disease based on motor dual-tasking: Evidence from the prospective MODEP study
Objective: To evaluate the predictive value of dual-task performance for future falls in patients with Parkinson's disease (PD). Background: Falls entail very severe health-related consequences…Neuropsychiatric, personality and non-motor correlates of impulse control disorders in recent onset Parkinson’s disease
Objective: To record the prevalence and clinical correlates of impulse control disorders (ICDs) in recent onset Parkinson's disease (PD) cases in the Tracking Parkinson's (PRoBaND)…A new tool to stage Parkinson’s disease PDCS (Parkinson’s disease composite scale): A pilot study on behalf of the European Parkinson’s disease association (EPDA)
Objective: The aim of PDCS is to create a simple scale able to measure the severity of patients, taking into account cardinal motor, non motor…Pantotenate kinase associated neurodegeneration (PKAN): Proposal for a clinical rating scale
Objective: To design and validate a quantitative method for the assessment of PKAN patients. Background: Despite advances in the research of novel therapies for PKAN,…Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible
Objective: To describe the clinical and imaging features of patients who developed dystonia-parkinsonism syndrome due to cyclosporine A(CsA). Background: CsA is an immunosuppressant widely used…A comparison of standards of care in Parkinson’s disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines
Objective: To compare standards of care for patients with Parkinson's disease (PD) between a general neurology clinic and specialist movement disorders clinic based on the…
- « Previous Page
- 1
- …
- 392
- 393
- 394
- 395
- 396
- …
- 405
- Next Page »